| scholarly article | Q13442814 |
| P356 | DOI | 10.1001/JAMA.298.13.1525 |
| P8608 | Fatcat ID | release_s43s5mrfcfbwxp45sunl2su2ri |
| P698 | PubMed publication ID | 17911497 |
| P5875 | ResearchGate publication ID | 5932503 |
| P50 | author | Clyde Yancy | Q30069510 |
| Gregg C. Fonarow | Q38543909 | ||
| Adrian F. Hernandez | Q40002155 | ||
| Sana M Al-Khatib | Q63018551 | ||
| Eric D. Peterson | Q63021326 | ||
| Nancy M Albert | Q64918217 | ||
| Kenneth A LaBresh | Q87720579 | ||
| Lesley H Curtis | Q88322421 | ||
| P2093 | author name string | Li Liang | |
| P433 | issue | 13 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | patient | Q181600 |
| heart failure | Q181754 | ||
| defibrillator | Q1450682 | ||
| hospitalization | Q3140971 | ||
| P304 | page(s) | 1525-1532 | |
| P577 | publication date | 2007-10-01 | |
| P1433 | published in | The Journal of the American Medical Association | Q1470970 |
| P1476 | title | Sex and racial differences in the use of implantable cardioverter-defibrillators among patients hospitalized with heart failure. | |
| P478 | volume | 298 |
| Q36543401 | A Report of the Women's Health Congress Workshop on The Health of Women of Color: A Critical Intersection at the Corner of Sex/Gender and Race/Ethnicity |
| Q39316738 | Acute heart failure syndromes: potential strategies to improve post-discharge outcomes |
| Q34205257 | Addressing disparities in sudden cardiac arrest care and the underutilization of effective therapies |
| Q37284866 | Age and gender trends in implantable cardioverter defibrillator utilization: a population based study |
| Q33828109 | Age differences in the use of implantable cardioverter-defibrillators among older patients hospitalized with heart failure |
| Q26823099 | Arrhythmias in women |
| Q36141618 | Association Between Comorbidities and Outcomes in Heart Failure Patients With and Without an Implantable Cardioverter-Defibrillator for Primary Prevention |
| Q34346069 | Beat-to-beat three-dimensional ECG variability predicts ventricular arrhythmia in ICD recipients |
| Q30419220 | Bundle-branch block morphology and other predictors of outcome after cardiac resynchronization therapy in Medicare patients |
| Q36794601 | Cardiac MRI scar patterns differ by sex in an implantable cardioverter-defibrillator and cardiac resynchronization therapy cohort |
| Q52685539 | Cardiac implantable electrical devices in women. |
| Q26781208 | Choice and Selection of Treatment Modalities for Cardiac Patients: An Interventional Cardiology Perspective |
| Q33541739 | Cholesterol treatment with statins: who is left out and who makes it to goal? |
| Q35056559 | Clinical effectiveness of CRT and ICD therapy in heart failure patients by racial/ethnic classification: insights from the IMPROVE HF registry |
| Q34572313 | Clinical effectiveness of cardiac resynchronization therapy versus medical therapy alone among patients with heart failure: analysis of the ICD Registry and ADHERE |
| Q30604593 | Clinical implications of chronic heart failure phenotypes defined by cluster analysis |
| Q34730989 | Clinical practice of defibrillator implantation after myocardial infarction: impact of implant time: results from the PreSCD II registry |
| Q37864961 | Definition of performance metrics and methods for screening for sudden cardiac arrest risk at a tertiary care medical center |
| Q39078681 | Differential survival for men and women from out-of-hospital cardiac arrest varies by age: results from the OPALS study. |
| Q36282612 | Disparities in heart failure and other cardiovascular diseases among women. |
| Q37363857 | Disparities in the provision of medical care: an outcome in search of an explanation |
| Q51802400 | Do gender differences exist in pacemaker implantation?--results of an obligatory external quality control program. |
| Q83248417 | Do physicians' attitudes toward implantable cardioverter defibrillator therapy vary by patient age, gender, or race? |
| Q38804927 | Eleven-year trends of inpatient pacemaker implantation in patients diagnosed with sick sinus syndrome |
| Q37776070 | European utilization of the implantable defibrillator: has 10 years changed the 'enigma'? |
| Q45420522 | Evaluation of the Charlson comorbidity index to predict early mortality in implantable cardioverter defibrillator patients. |
| Q57630440 | Factors Associated with Improvement in Guideline-Based Use of ICDs in Eligible Heart Failure Patients |
| Q35201550 | Factors influencing utilization of the primary prevention implantable defibrillator |
| Q37241690 | Failure to reassess ejection fraction after acute myocardial infarction in potential implantable cardioverter/defibrillator candidates: insights from the Translational Research Investigating Underlying disparities in acute Myocardial infarction Pati |
| Q48140179 | Gaps in physician knowledge are associated with under-referral for evidence-based implantable cardioverter defibrillator therapy: How can we improve care? |
| Q57630230 | Gender Bias Trends in Implantable Cardioverter-Defibrillator Therapy |
| Q55322366 | Gender Differences in Clinical Outcomes after Catheter Ablation of Atrial Fibrillation. |
| Q38954398 | Gender Disparities Across the Spectrum of Advanced Cardiac Therapies: Real or Imagined? |
| Q37078756 | Gender differences in the pathophysiology, clinical presentation, and outcomes of ischemic heart failure |
| Q50002892 | Gender differences in the use of primary prevention ICDs in New Zealand patients with heart failure |
| Q37516990 | Gender disparities in red blood cell transfusion in elective surgery: a post hoc multicentre cohort study |
| Q38067775 | Gender disparity in cardiovascular disease: bias or biology? |
| Q39341805 | Gender, Racial, and Health Insurance Differences in the Trend of Implantable Cardioverter-Defibrillator (ICD) Utilization: A United States Experience Over the Last Decade. |
| Q50850559 | Gender-specific differences in clinical outcome of primary prevention implantable cardioverter defibrillator recipients. |
| Q36790992 | Geographic variation in implantable cardioverter-defibrillator use and heart failure survival |
| Q83569411 | Heart failure in women |
| Q86623276 | Heart failure in women |
| Q37585303 | Heart failure in women: epidemiology, biology and treatment |
| Q37337981 | Heart failure–associated hospitalizations in the United States |
| Q36085763 | Heart rate at hospital discharge in patients with heart failure is associated with mortality and rehospitalization |
| Q34209345 | Impact of a recent lead recall on utilization of implantable cardioverter defibrillators: data from the NCDR ICD Registry™. |
| Q90747330 | Impact of sex, socio-economic status, and remoteness on therapy and survival in heart failure |
| Q93832830 | Implantable cardioverter defibrillators given more often to men |
| Q37855663 | Implantable cardioverter-defibrillator implementation in acute heart failure syndromes: unanswered questions |
| Q45044846 | Inequity of access to implantable cardioverter defibrillator therapy in England: possible causes of geographical variation in implantation rates |
| Q33582186 | Influence of healthy candidate bias in assessing clinical effectiveness for implantable cardioverter-defibrillators: cohort study of older patients with heart failure |
| Q53123968 | Lack of current implantable cardioverter defibrillator guidelines application for primary prevention of sudden cardiac death in Latin American patients with heart failure: a cross-sectional study. |
| Q36434445 | Low rate of secondary prevention ICDs in the general population: multiple-year multiple-source surveillance of sudden cardiac death in the Oregon Sudden Unexpected Death Study |
| Q37197086 | Microvolt T-wave alternans testing for ventricular arrhythmia risk stratification |
| Q46463387 | No gender survival difference in a population of patients with chronic heart failure related to left ventricular systolic dysfunction and receiving optimal medical therapy |
| Q24607930 | Non-evidence-based ICD implantations in the United States |
| Q33940619 | Outcomes in African Americans undergoing cardioverter-defibrillator implantation for primary prevention of sudden cardiac death: findings from the Prospective Observational Study of Implantable Cardioverter-Defibrillators (PROSE-ICD). |
| Q37435170 | Outcomes in heart failure patients referred for consideration of implantable cardioverter defibrillator for primary prophylaxis of sudden cardiac death: what are the risks of waiting? |
| Q34040404 | Patient and cardiologist perceptions on decision making for implantable cardioverter-defibrillators: a qualitative study |
| Q38252697 | Patients' perception of implantable cardioverter defibrillator deactivation at the end of life. |
| Q36154941 | Payment source, quality of care, and outcomes in patients hospitalized with heart failure |
| Q35915893 | Physicians' knowledge and attitudes regarding implantable cardioverter-defibrillators. |
| Q34517911 | Predictors of implantable cardioverter-defibrillator use in patients with ischemic cardiomyopathy |
| Q51382605 | Predictors of sustained ventricular arrhythmia episodes in patients with primary ICD indication: male gender and AF in primary ICD prophylaxis. |
| Q38095646 | Prevention and treatment of cardiovascular disease in women: the obstetric-gynecologist's point of view. |
| Q31044974 | Primary Prevention Implantable Cardioverter Defibrillator (ICD) Therapy in Women-Data From a Multicenter French Registry |
| Q35708346 | Primary prevention implantable cardioverter-defibrillators and survival in older women |
| Q35591941 | Primary prevention implantable cardioverter-defibrillators in older racial and ethnic minority patients |
| Q37017442 | Quality of care and outcomes among patients with heart failure and chronic kidney disease: A Get With the Guidelines -- Heart Failure Program study |
| Q90371628 | Race, ethnicity, and the risk of sudden death |
| Q36533940 | Racial and gender disparities among patients with gout |
| Q34064795 | Racial and gender trends in the use of implantable cardioverter-defibrillators among Medicare beneficiaries between 1997 and 2003. |
| Q64262544 | Racial and sex disparities in resource utilization and outcomes of multi-vessel percutaneous coronary interventions (a 5-year nationwide evaluation in the United States) |
| Q34615013 | Racial differences in sudden cardiac death |
| Q37481451 | Racial differences in survival after in-hospital cardiac arrest |
| Q37328699 | Racial differences in the prevalence and outcomes of atrial fibrillation among patients hospitalized with heart failure |
| Q64241799 | Relationship Between Hospital Characteristics and Early Adoption of Angiotensin-Receptor/Neprilysin Inhibitor Among Eligible Patients Hospitalized for Heart Failure |
| Q34621028 | Sex Difference in Clinical Outcome of Patients With Implantable Cardioverter-defibrillator |
| Q37469058 | Sex Differences In Outcomes Of Ablation Of Atrial Fibrillation |
| Q36458863 | Sex Differences in Utilisation and Response to Implantable Device Therapy |
| Q90554052 | Sex Differences in the Coronary System |
| Q34060039 | Sex and gender differences in myocarditis and dilated cardiomyopathy |
| Q51229352 | Sex differences in the prevalence, symptoms, and associated features of migraine, probable migraine and other severe headache: results of the American Migraine Prevalence and Prevention (AMPP) Study. |
| Q36173674 | Sex matters: gender disparities in quality and outcomes of care |
| Q34836591 | Sex- and gender-specific research priorities for the emergency management of heart failure and acute arrhythmia: proceedings from the 2014 Academic Emergency Medicine Consensus Conference Cardiovascular Research Workgroup |
| Q55257385 | Sex-specific precision medicine: targeting CRT-D and other cardiovascular interventions to those most likely to benefit. |
| Q35070652 | Short- and long-term rehospitalization and mortality for heart failure in 4 racial/ethnic populations |
| Q37548979 | Socioeconomic disparities in the use of cardioprotective medications among patients with peripheral artery disease: an analysis of the American College of Cardiology's NCDR PINNACLE Registry |
| Q89733605 | State of the Science in Women's Cardiovascular Disease: A Canadian Perspective on the Influence of Sex and Gender |
| Q38827341 | Study Design and Cohort Description of DEFIB-WOMEN: A National Danish Study in Patients with an ICD. |
| Q46069620 | Subject of the year: who are we missing, who are we overtreating, and who is best served? Refining the prescription of implantable cardioverter-defibrillator therapy |
| Q38174217 | Sudden cardiac death: a critical appraisal of the implantable cardioverter defibrillator |
| Q38793773 | Survival in Women Versus Men Following Implantation of Pacemakers, Defibrillators, and Cardiac Resynchronization Therapy Devices in a Large, Nationwide Cohort |
| Q40311907 | Temporal Trends Over a Decade of Defibrillator Therapy for Primary Prevention in Community Practice |
| Q38241097 | The current state of ethnic and racial disparities in cardiovascular care: lessons from the past and opportunities for the future |
| Q33829386 | The heart truth professional education campaign on women and heart disease: needs assessment and evaluation results |
| Q37357346 | The implantable cardioverter defibrillator: its history, current psychological impact and future. |
| Q43770396 | Treatment of heart failure in African Americans--a call to action. |
| Q45069690 | Trends in the use of implantable cardioverter defibrillators in Australia: a 10-year nationwide study from 2000-2009. |
| Q36896779 | Trends in use of implantable cardioverter-defibrillator therapy among patients hospitalized for heart failure: have the previously observed sex and racial disparities changed over time? |
| Q83327414 | Twenty-five years of implantable defibrillator practice in the USA: are we ready for globalization? |
| Q38410791 | Under-Utilization of Implantable Cardioverter Defibrillators in Patients with Heart Failure - The Current State of Sudden Cardiac Death Prophylaxis |
| Q37711240 | Underutilization of Implantable Cardioverter Defibrillator in Primary Prevention of Sudden Cardiac Arrest |
| Q43596856 | Unidentified candidates for cardiac resynchronization therapy: guideline adherence in a large academic outpatient clinic in the Netherlands |
| Q33819136 | Utilization rates of implantable cardioverter-defibrillators for primary prevention of sudden cardiac death: a 2012 calculation for a midwestern health referral region |
| Q90706342 | Women Hospitalized for Acute on Chronic Decompensated Systolic Heart Failure Receive Less Furosemide Compared to Men |
Search more.